Endometriosis and Contemporary Pain Science: Five “Simple Rules” for Managing Symptoms With Different Neurobiological Mechanisms

Paolo Vercellini, Giulia Emily Cetera, Noemi Salmeri, Paola Viganò, Edgardo Somigliana
{"title":"Endometriosis and Contemporary Pain Science: Five “Simple Rules” for Managing Symptoms With Different Neurobiological Mechanisms","authors":"Paolo Vercellini, Giulia Emily Cetera, Noemi Salmeri, Paola Viganò, Edgardo Somigliana","doi":"10.1111/1471-0528.18201","DOIUrl":null,"url":null,"abstract":"<p>Moreira and Oliveira highlight the shortcomings of the current management of endometriosis symptoms based on exclusively lesion-centred models, and promote patient categorisation according to an individual's predominant neurobiological mechanism, that is, nociceptive, neuropathic, or nociplastic pain [<span>1</span>]. This should allow the tailored targeting of the different pain components, thus potentially optimising clinical outcomes.</p>\n<p>We agree with the authors' conceptual framework [<span>2, 3</span>] but, as accurately discriminating between the above pain phenotypes may not be straightforward, we propose five “simple rules” to guide inexperienced clinicians. Moreover, a comprehensive multimodal therapeutic approach is resource intensive, as physiotherapists, pain specialists, psychotherapists, gastroenterologists, urologists, and dieticians may be involved. Selected interventions, appropriately prescribed for patients with specific pain mechanisms, could avoid undue burden on already overstretched public health systems.</p>\n<p>First, suspect early-onset endometriosis in adolescents complaining of painful periods and abdominopelvic pain (primarily nociceptive pain), as its prevalence in severely symptomatic teenagers is high even when ultrasound is negative [<span>2, 4</span>]. Diagnostic delay promotes afferent hypersensitivity and fosters the transition from peripheral to central sensitisation [<span>2</span>].</p>\n<p>Second, at diagnosis, suppress recurrent ovulatory cycles with continuous bioequivalent oestradiol–progestogen combinations or progestogen monotherapies. Generally, ethinyl-oestradiol is pro-inflammatory, whereas progestogens are anti-inflammatory [<span>4</span>]. Prompt secondary prevention could avoid disease progression, symptom worsening, and the transition from localised pelvic pain to widespread nociplastic pain.</p>\n<p>Third, along with potentially different neurobiological mechanisms, evaluate symptom type. Menstrual pain should be relieved by establishing amenorrhoea; deep dyspareunia may benefit from the excision of deep lesions and treatment of pelvic floor hypertonicity.</p>\n<p>Fourth, try a three-month course of a GnRH agonist or antagonist without ‘add-back’ therapy in non-responders to first-line medical treatment to differentiate between hormone-dependent (presumably mostly nociceptive) and hormone-independent (presumably mostly nociplastic) pain [<span>4</span>]. This pharmacological test is practicable in any clinical setting, overcomes the potentially confusing uncertainties regarding progesterone resistance, and identifies the best candidates for additional interventions such as aerobic exercise, cognitive behavioural therapy, anti-inflammatory diet, pelvic floor rehabilitation, acupuncture, and non-hormonal pharmacological therapies. In GnRH analogue non-responders, the role of endometriosis as the sole or main pain trigger should be carefully reconsidered [<span>2, 4</span>].</p>\n<p>Fifth, administer yourself as a medication [<span>3</span>]. Listening with a warm and non-judgmental approach, providing clear explanations and reassurance, avoiding pessimistic predictions, offering practical advice on treatment plans and self-management strategies can reduce the ‘<i>maladaptive cognitive affective responses to pain episodes that exert a direct influence on peripheral nociceptive processing via descending pathways</i>’ [<span>1, 3</span>]. Words can help coping with pain, reduce catastrophising, anxiety, and depression, facilitate resumption of social activities and improve relationships.</p>\n<p>There is a pressing need to raise awareness of the multifaceted nature of endometriosis-associated pain. However, this should be combined with timely diagnosis, secondary prevention of disease progression, primary prevention of peripheral and central sensitisation and nociplastic pain onset, and appropriate empathy. Humanistic medicine is inexpensive, does not consume precious resources, and could be available everywhere without disparities. A neurobiological pain phenotype categorisation approach is crucial but demanding, requiring physician knowledge, motivation, and sufficient time for consultation. These simple rules may ease the transition toward a holistic approach to “the pains of endometriosis”.</p>","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"42 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJOG: An International Journal of Obstetrics & Gynaecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/1471-0528.18201","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Moreira and Oliveira highlight the shortcomings of the current management of endometriosis symptoms based on exclusively lesion-centred models, and promote patient categorisation according to an individual's predominant neurobiological mechanism, that is, nociceptive, neuropathic, or nociplastic pain [1]. This should allow the tailored targeting of the different pain components, thus potentially optimising clinical outcomes.

We agree with the authors' conceptual framework [2, 3] but, as accurately discriminating between the above pain phenotypes may not be straightforward, we propose five “simple rules” to guide inexperienced clinicians. Moreover, a comprehensive multimodal therapeutic approach is resource intensive, as physiotherapists, pain specialists, psychotherapists, gastroenterologists, urologists, and dieticians may be involved. Selected interventions, appropriately prescribed for patients with specific pain mechanisms, could avoid undue burden on already overstretched public health systems.

First, suspect early-onset endometriosis in adolescents complaining of painful periods and abdominopelvic pain (primarily nociceptive pain), as its prevalence in severely symptomatic teenagers is high even when ultrasound is negative [2, 4]. Diagnostic delay promotes afferent hypersensitivity and fosters the transition from peripheral to central sensitisation [2].

Second, at diagnosis, suppress recurrent ovulatory cycles with continuous bioequivalent oestradiol–progestogen combinations or progestogen monotherapies. Generally, ethinyl-oestradiol is pro-inflammatory, whereas progestogens are anti-inflammatory [4]. Prompt secondary prevention could avoid disease progression, symptom worsening, and the transition from localised pelvic pain to widespread nociplastic pain.

Third, along with potentially different neurobiological mechanisms, evaluate symptom type. Menstrual pain should be relieved by establishing amenorrhoea; deep dyspareunia may benefit from the excision of deep lesions and treatment of pelvic floor hypertonicity.

Fourth, try a three-month course of a GnRH agonist or antagonist without ‘add-back’ therapy in non-responders to first-line medical treatment to differentiate between hormone-dependent (presumably mostly nociceptive) and hormone-independent (presumably mostly nociplastic) pain [4]. This pharmacological test is practicable in any clinical setting, overcomes the potentially confusing uncertainties regarding progesterone resistance, and identifies the best candidates for additional interventions such as aerobic exercise, cognitive behavioural therapy, anti-inflammatory diet, pelvic floor rehabilitation, acupuncture, and non-hormonal pharmacological therapies. In GnRH analogue non-responders, the role of endometriosis as the sole or main pain trigger should be carefully reconsidered [2, 4].

Fifth, administer yourself as a medication [3]. Listening with a warm and non-judgmental approach, providing clear explanations and reassurance, avoiding pessimistic predictions, offering practical advice on treatment plans and self-management strategies can reduce the ‘maladaptive cognitive affective responses to pain episodes that exert a direct influence on peripheral nociceptive processing via descending pathways’ [1, 3]. Words can help coping with pain, reduce catastrophising, anxiety, and depression, facilitate resumption of social activities and improve relationships.

There is a pressing need to raise awareness of the multifaceted nature of endometriosis-associated pain. However, this should be combined with timely diagnosis, secondary prevention of disease progression, primary prevention of peripheral and central sensitisation and nociplastic pain onset, and appropriate empathy. Humanistic medicine is inexpensive, does not consume precious resources, and could be available everywhere without disparities. A neurobiological pain phenotype categorisation approach is crucial but demanding, requiring physician knowledge, motivation, and sufficient time for consultation. These simple rules may ease the transition toward a holistic approach to “the pains of endometriosis”.

子宫内膜异位症与当代疼痛科学:管理不同神经生物学机制症状的五个“简单规则”
Moreira和Oliveira强调了目前仅以病变为中心的模型为基础的子宫内膜异位症症状管理的缺点,并促进了根据个体主要的神经生物学机制(即伤害性、神经性或伤害性疼痛)对患者进行分类。这应该允许针对不同的疼痛成分进行量身定制,从而潜在地优化临床结果。我们同意作者的概念框架[2,3],但由于准确区分上述疼痛表型可能并不简单,我们提出了五个“简单规则”来指导经验不足的临床医生。此外,综合的多模式治疗方法是资源密集的,因为物理治疗师、疼痛专家、心理治疗师、胃肠病学家、泌尿科医生和营养师都可能参与其中。针对具有特定疼痛机制的患者适当开处方的选定干预措施可以避免给已经不堪重负的公共卫生系统带来不必要的负担。首先,怀疑早发性子宫内膜异位症发生在主诉痛经和骨盆疼痛(主要是痛觉性疼痛)的青少年中,因为其在症状严重的青少年中患病率很高,即使超声检查为阴性[2,4]。诊断延迟促进传入超敏反应,并促进从外周到中枢的过渡。其次,在诊断时,通过持续的生物等效雌二醇-孕激素联合治疗或孕激素单药治疗来抑制复发性排卵周期。一般来说,炔雌醇是促炎的,而孕激素是抗炎的。及时的二级预防可以避免疾病进展、症状恶化以及从局部盆腔疼痛向广泛的伤害性疼痛的转变。第三,结合潜在的不同神经生物学机制,评估症状类型。经期疼痛应通过闭经来缓解;深度性交困难可能受益于深部病变的切除和盆底高张力的治疗。第四,在对一线药物治疗无反应的患者中,尝试三个月的GnRH激动剂或拮抗剂疗程,而不进行“附加”治疗,以区分激素依赖性(可能主要是伤害性的)和激素非依赖性(可能主要是伤害性的)疼痛。这种药理学试验在任何临床环境中都是可行的,克服了有关孕酮抵抗的潜在混淆不确定性,并确定了有氧运动、认知行为疗法、抗炎饮食、骨盆底康复、针灸和非激素药物治疗等额外干预的最佳候选。在GnRH类似物无应答者中,应仔细考虑子宫内膜异位症作为唯一或主要疼痛触发因素的作用[2,4]。第五,把自己当作一个药物管理员来管理。以温暖和非评判的方式倾听,提供清晰的解释和安慰,避免悲观的预测,就治疗计划和自我管理策略提供实用的建议,可以减少“对疼痛发作的不适应认知情感反应,这种反应通过下行通路直接影响外周伤害性加工”[1,3]。语言可以帮助应对痛苦,减少灾难,焦虑和抑郁,促进社会活动的恢复,改善关系。迫切需要提高对子宫内膜异位症相关疼痛的多面性的认识。然而,这应与及时诊断、疾病进展的二级预防、外周和中枢致敏和伤害性疼痛发作的一级预防以及适当的共情相结合。人文医学价格低廉,不消耗宝贵的资源,可以在任何地方获得,而不存在差距。神经生物学疼痛表型分类方法至关重要,但要求很高,需要医生的知识、动机和足够的咨询时间。这些简单的规则可能会缓解过渡到一个整体的方法,以“子宫内膜异位症的痛苦”。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信